To understand the molecular drivers of distinct subtypes of pediatric B-ALL, we incorporated existing genomic and transcriptomic data with newly generated global proteomic and phosphoproteomic profiles for a cohort of patients with either ETV6::RUNX1 B-ALL or Ph-like B-ALL. The gene discussed is RUNX1; the disease is precursor B-cell acute lymphoblastic leukemia.